Table 1.
Modality | Capabilities | Application | Contrast Agents/ Radionuclide Tracers |
||
---|---|---|---|---|---|
Anatomical | Molecular/ Functional |
Benefits | Limitations | ||
Ultrasound | X | Rapid, accurate, low cost, reproducibility, widely available | Limited resolution, image interpretation difficult, artifacts common | Microbubbles | |
| |||||
CT | X | Rapid, high resolution, useful for early clinical followup | Ionizing radiation, requires contrast agent | Iodine or Barium | |
| |||||
MRI | X | Soft tissue contrast, high resolution | High cost, large equipment required | Gadolinium chelates | |
X | Customizable molecular targeting, cell tracking | Limited sensitivity, requires contrast agent | USPIOs or gadolinium chelates | ||
| |||||
NIRF | X | Low cost, widely available | Photobleaching, low quantum yield, shallow tissue penetration | MMPSense, scVEGF/Cy, RGD-HFn-Cy5.5 | |
| |||||
Bioluminescence | X | High sensitivity, high specificity | Shallow tissue penetration, requires transgenic modification | Exotic transgenic cells combined with luciferin | |
| |||||
SPECT | X | 3D imaging, widely available, highly sensitive, simultaneous imaging of multiple processes | Limited temporal resolution, few radionuclide tracers | 99TC, 111In, 201Tl, 123I, 131I | |
| |||||
PET | X | Quantification of metabolism and blood flow, high sensitivity, many radionuclide tracers available | High cost, limited availability, large equipment required, short tracer half-life, single process evaluation | 18F, 11C, 13N, 15O, 82RB |